WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011146583) NANOPARTICULATE CINACALCET FORMULATIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/146583    International Application No.:    PCT/US2011/036949
Publication Date: 24.11.2011 International Filing Date: 18.05.2011
IPC:
A61K 9/14 (2006.01), A61K 31/137 (2006.01)
Applicants: ELAN PHARMA INTERNATIONAL LIMITED [IE/IE]; Monksland, Athlone County Westmeath (IE) (For All Designated States Except US).
NEVILLE, Deborah [US/US]; (US) (For US Only).
JENKINS, Scott [US/US]; (US) (For US Only).
MANSER, David [GB/GB]; (IE) (For US Only)
Inventors: NEVILLE, Deborah; (US).
JENKINS, Scott; (US).
MANSER, David; (IE)
Agent: SIMKIN, Michele, M.; FOLEY & LARDNER LLP Washington Harbour 3000 K Street, NW, 6th Floor Washington, DC 20007-5143 (US)
Priority Data:
61/346,331 19.05.2010 US
Title (EN) NANOPARTICULATE CINACALCET FORMULATIONS
(FR) FORMULATIONS DE CINACALCET NANOPARTICULAIRE
Abstract: front page image
(EN)The invention is directed to compositions comprising stable nanoparticulate cinacalcet or a salt thereof. The composition can exhibit an improved dissolution rate, improved bioavailability, and reduced difference in absorption when administered orally under fed as compared to fasting conditions. The invention also encompasses methods of making and using such compositions.
(FR)L'invention porte sur des compositions qui comprennent du cinacalcet nanoparticulaire stable ou un sel de celui-ci. La composition peut présenter une vitesse de dissolution et une biodisponibilité améliorées, ainsi qu'une différence réduite d'absorption lorsqu'elle est administrée oralement dans des conditions d'alimentation par comparaison avec des conditions de jeûne. L'invention porte également sur des procédés de fabrication et d'utilisation de telles compositions.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)